Olivia R. Buonarati, Nidia Quillinan, K. Ulrich Bayer. bioRxiv 2025.
tatCN19o. CPC Scientific; Coultrap et al. 2011. N/A (custom peptide).
J. Zeng, G.W.Z. Loi, E.N. Saipuljumri, M.A. Romero Durán, O. Silva-García, J.M. Perez-Aguilar, V.M. Baizabal-Aguirre, & C.H. Lo. Proc. Natl. Acad. Sci. U.S.A. 2024 121 (14).
FKC (FKCRRWQWRMKK-NH2), rhodamine-conjugated FKC (Rho-FKCRRWQWRMKK-NH2), and IDR (VQRWLIVWRIRK-NH2) peptides were synthesized using solid phase F-moc chemistry by CPC Scientific, Inc. with a purity greater than 95%.
CPC Scientific provides both research-grade and clinical-grade oligonucleotide manufacturing services to our clients. With our strong commitment to innovation, we provide full lifecycle services, supporting peptide-based therapeutics from early discovery through clinical development and into commercial production. Using solid-phase synthesis, we offer custom oligo development, scale-up, and analytical testing, supporting clients across the entire lifecycle from discovery to clinical stages. Our expertise in oligonucleotide synthesis, with a wide range of modifications, enables us to deliver tailored solutions for diverse client needs.
Line, J.E.; Seal, B.S.; Garrish, J.K. Appl. Microbiol. 2022, 2, 688–700.
Peptides were synthesized using standard solid-phase(Fmoc) chemistry with a peptide synthesizer (CPC Scientific Inc., Sunnyvale, CA 94089,USA, C12K-2β12 [..]
